Suppr超能文献

透明细胞乳头状肾细胞癌:miRNA 表达谱分析,并与透明细胞肾细胞癌和乳头状肾细胞癌进行比较。

Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.

机构信息

Department of Pathology, Johns Hopkins University, Baltimore, MD 21287, USA.

Department of Oncology, Johns Hopkins University, Baltimore, MD 21287, USA.

出版信息

Hum Pathol. 2014 Jun;45(6):1130-8. doi: 10.1016/j.humpath.2014.01.013. Epub 2014 Jan 31.

Abstract

Clear cell papillary renal cell carcinoma (CCPRCC) is a low-grade renal neoplasm with morphological characteristics mimicking both clear cell renal cell carcinoma (CCRCC) and papillary renal cell carcinoma (PRCC). However, despite some overlapping features, their morphological, immunohistochemical, and molecular profiles are distinct. Micro-RNAs (miRNAs) are small noncoding RNAs that play a crucial role in regulating gene expression and are involved in various biological processes, including cancer development. To better understand the biology of this tumor, we aimed to analyze the miRNA expression profile of a set of CCPRCC using microarray and quantitative reverse transcription-polymerase chain reaction. A total of 15 cases diagnosed as CCPRCC were used in this study. Among the most differentially expressed miRNA in CCPRCC, we found miR-210, miR-122, miR-34a, miR-21, miR-34b*, and miR-489 to be up-regulated, whereas miR-4284, miR-1202, miR-135a, miR-1973, and miR-204 were down-regulated compared with normal renal parenchyma. To identify consensus of differentially regulated miRNA between CCPRCC, CCRCC, and PRCC, we additionally determined differential miRNA expression using 2 publically available microarray data sets from the NCBI Gene Expression Omnibus database (GSE41282 and GSE3798). This comparison revealed that the miRNA expression profile of CCPRCC shows some overlapping characteristics between CCRCC and PRCC. Moreover, CCPRCC lacks dysregulation of important miRNAs typically associated with aggressive behavior. In summary, we describe the miRNA expression profile of a relatively infrequent type of renal cancer. Our results may help in understanding the molecular underpinning of this newly recognized entity.

摘要

透明细胞乳头状肾细胞癌 (CCPRCC) 是一种低级别肾肿瘤,其形态特征类似于透明细胞肾细胞癌 (CCRCC) 和乳头状肾细胞癌 (PRCC)。然而,尽管有一些重叠特征,但它们的形态、免疫组织化学和分子特征是不同的。微小 RNA (miRNA) 是一种小的非编码 RNA,在调节基因表达中起着至关重要的作用,并参与包括癌症发展在内的各种生物过程。为了更好地理解这种肿瘤的生物学特性,我们旨在使用微阵列和定量逆转录聚合酶链反应分析一组 CCPRCC 的 miRNA 表达谱。本研究共使用 15 例诊断为 CCPRCC 的病例。在 CCPRCC 中差异表达最显著的 miRNA 中,我们发现 miR-210、miR-122、miR-34a、miR-21、miR-34b*和 miR-489 上调,而 miR-4284、miR-1202、miR-135a、miR-1973 和 miR-204 下调与正常肾实质相比。为了确定 CCPRCC、CCRCC 和 PRCC 之间差异调节 miRNA 的共识,我们还使用 NCBI 基因表达综合数据库 (GSE41282 和 GSE3798) 中两个公开的微阵列数据集来确定差异 miRNA 表达。这一比较表明,CCPRCC 的 miRNA 表达谱在 CCRCC 和 PRCC 之间显示出一些重叠特征。此外,CCPRCC 缺乏与侵袭性行为相关的重要 miRNA 的失调。总之,我们描述了一种相对罕见的肾癌的 miRNA 表达谱。我们的结果可能有助于理解这种新认识实体的分子基础。

相似文献

3
MicroRNA expression profiling of Xp11 renal cell carcinoma.
Hum Pathol. 2017 Sep;67:18-29. doi: 10.1016/j.humpath.2017.03.011. Epub 2017 Apr 12.
9
Characteristics of Clear Cell Papillary Renal Cell Carcinoma (ccpRCC).
Int J Mol Sci. 2021 Dec 23;23(1):151. doi: 10.3390/ijms23010151.
10
Cytomorphologic analysis of clear cell papillary renal cell carcinoma: Distinguishing diagnostic features.
Cancer Cytopathol. 2021 Mar;129(3):192-203. doi: 10.1002/cncy.22355. Epub 2020 Oct 9.

引用本文的文献

1
Exploring the Role of MicroRNAs in Progesterone and Estrogen Receptor Expression in Endometriosis.
Biomedicines. 2024 Sep 28;12(10):2218. doi: 10.3390/biomedicines12102218.
3
Cystic Clear Cell Renal Cell Carcinoma: A Morphological and Molecular Reappraisal.
Cancers (Basel). 2023 Jun 26;15(13):3352. doi: 10.3390/cancers15133352.
4
Renal Cell Carcinoma in End-Stage Renal Disease: A Review and Update.
Biomedicines. 2022 Mar 11;10(3):657. doi: 10.3390/biomedicines10030657.
5
Characteristics of Clear Cell Papillary Renal Cell Carcinoma (ccpRCC).
Int J Mol Sci. 2021 Dec 23;23(1):151. doi: 10.3390/ijms23010151.
7
Relationship between miR-155 expression and clear cell papillary renal cell carcinoma in the dialyzed kidney.
IJU Case Rep. 2021 Mar 15;4(3):127-131. doi: 10.1002/iju5.12258. eCollection 2021 May.
9
Endogenous miR-204 Protects the Kidney against Chronic Injury in Hypertension and Diabetes.
J Am Soc Nephrol. 2020 Jul;31(7):1539-1554. doi: 10.1681/ASN.2019101100. Epub 2020 Jun 2.

本文引用的文献

3
MicroRNA deregulation in polycythemia vera and essential thrombocythemia patients.
Blood Cells Mol Dis. 2013 Mar;50(3):190-5. doi: 10.1016/j.bcmd.2012.11.009. Epub 2012 Dec 21.
4
Clear cell papillary renal cell carcinoma: differential diagnosis and extended immunohistochemical profile.
Mod Pathol. 2013 May;26(5):697-708. doi: 10.1038/modpathol.2012.204. Epub 2012 Dec 14.
6
Identification of metastamirs as metastasis-associated microRNAs in clear cell renal cell carcinomas.
Int J Biol Sci. 2012;8(10):1363-74. doi: 10.7150/ijbs.5106. Epub 2012 Oct 28.
7
MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer.
Cancer Discov. 2012 Mar;2(3):236-47. doi: 10.1158/2159-8290.CD-11-0219. Epub 2012 Jan 5.
9
Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients.
Genes Chromosomes Cancer. 2012 Jul;51(7):707-16. doi: 10.1002/gcc.21957. Epub 2012 Apr 10.
10
MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma.
Carcinogenesis. 2012 Feb;33(2):294-300. doi: 10.1093/carcin/bgr286. Epub 2011 Dec 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验